Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Cucchiara

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
European Urology Focus|January 11, 2021
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and BeyondGiorgio Gandaglia, Riccardo Leni, Nicola Fossati, et al.
European Urology|June 29, 2026
Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysisAlessandro Viti, Simone Scuderi, Vito Cucchiara, et al.
The Journal of Sexual Medicine|January 26, 2016
Comparison of Treatment Emergent Adverse Events in Men With Premature Ejaculation Treated With Dapoxetine and Alternate Oral Treatments: Results From a Large Multinational Observational TrialPaolo Verze, Tommaso Cai, Carlo Magno, et al.
European Urology|February 22, 2015
A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical ProstatectomyAndrea Gallina, Marco Bianchi, Giorgio Gandaglia, et al.
Current Opinion in Urology|December 2, 2016
The role of prostatic inflammation in the development and progression of benign and malignant diseasesGiorgio Gandaglia, Emanuele Zaffuto, Nicola Fossati, et al.
European Urology|April 8, 2018
Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer?Gianluca Giannarini, Nicola Fossati, Giorgio Gandaglia, et al.
Cancers|March 10, 2017
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer TherapyVito Cucchiara, Joy C Yang, Vincenzo Mirone, et al.
The Journal of Urology|February 22, 2021
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic ReviewNicholas H Chakiryan, Aaron Dahmen, Vito Cucchiara, et al.
Cancer Biology & Medicine|May 26, 2021
A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancerDenise Drago, Annapaola Andolfo, Ettore Mosca, et al.
Urology Practice|August 4, 2023
Fascial Layers in Nerve Sparing Robot-Assisted Radical ProstatectomyGiorgio Gandaglia, Alberto Briganti, Nazareno Suardi, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
European Urology Focus|January 11, 2021
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and BeyondGiorgio Gandaglia, Riccardo Leni, Nicola Fossati, et al.
European Urology|June 29, 2026
Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysisAlessandro Viti, Simone Scuderi, Vito Cucchiara, et al.
The Journal of Sexual Medicine|January 26, 2016
Comparison of Treatment Emergent Adverse Events in Men With Premature Ejaculation Treated With Dapoxetine and Alternate Oral Treatments: Results From a Large Multinational Observational TrialPaolo Verze, Tommaso Cai, Carlo Magno, et al.
European Urology|February 22, 2015
A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical ProstatectomyAndrea Gallina, Marco Bianchi, Giorgio Gandaglia, et al.
Current Opinion in Urology|December 2, 2016
The role of prostatic inflammation in the development and progression of benign and malignant diseasesGiorgio Gandaglia, Emanuele Zaffuto, Nicola Fossati, et al.
European Urology|April 8, 2018
Will Image-guided Metastasis-directed Therapy Change the Treatment Paradigm of Oligorecurrent Prostate Cancer?Gianluca Giannarini, Nicola Fossati, Giorgio Gandaglia, et al.
Cancers|March 10, 2017
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer TherapyVito Cucchiara, Joy C Yang, Vincenzo Mirone, et al.
The Journal of Urology|February 22, 2021
Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic ReviewNicholas H Chakiryan, Aaron Dahmen, Vito Cucchiara, et al.
Cancer Biology & Medicine|May 26, 2021
A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancerDenise Drago, Annapaola Andolfo, Ettore Mosca, et al.
Urology Practice|August 4, 2023
Fascial Layers in Nerve Sparing Robot-Assisted Radical ProstatectomyGiorgio Gandaglia, Alberto Briganti, Nazareno Suardi, et al.
Pageof 9